Cargando…
Epidermal growth factor receptor status of histological sub-types of breast cancer.
The histological breakdown of a consecutive series of 264 surgically resected malignant lesions of the breast was studied. Oestrogen and epidermal growth factor receptor status was quantified and presented along with size and lymph node status of the non-ductal lesions. Those non-ductal tumours cont...
Autores principales: | Sainsbury, J. R., Nicholson, S., Angus, B., Farndon, J. R., Malcolm, A. J., Harris, A. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1988
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246782/ https://www.ncbi.nlm.nih.gov/pubmed/3207600 |
Ejemplares similares
-
Epidermal Growth Factor Receptors and Breast Cancer
por: Farndon, J. R., et al.
Publicado: (1989) -
Epidermal growth factor receptor (EGFr) status associated with failure of primary endocrine therapy in elderly postmenopausal patients with breast cancer.
por: Nicholson, S., et al.
Publicado: (1988) -
Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup.
por: Nicholson, S., et al.
Publicado: (1991) -
Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.
por: Wright, C., et al.
Publicado: (1992) -
Value of epidermal growth factor receptor status compared with growth fraction and other factors for prognosis in early breast cancer.
por: Gasparini, G., et al.
Publicado: (1992)